1. Home
  2. Live Updates
  3. Biosimilars council

Live Breaking News & Updates on Biosimilars council

Stay informed with the latest breaking news from Biosimilars council on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biosimilars council and stay connected to the pulse of your community

PBM rebate schemes to suppress biosimilar Humira cost patients $6B, IQVIA analysis finds

The Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients.

Craig-burton , David-gaugh , Biosimilars-council , Association-for-accessible-medicines ,

AAM: Avalere study shows PBMs continue to block patient access to biosimilars

The analysis reiterates that biosimilar challenges are not limited to the Humira market.

Association-for-accessible-medicines , Biosimilars-council , Cigna , Avalere-health , Accessible-medicines , Medicare-part , United-healthcare , Medicare-advantage ,

March-In Drive Loses a Wheel: Generics Industry Says No to Biden Framework

March-In Drive Loses a Wheel: Generics Industry Says No to Biden Framework
ipwatchdog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipwatchdog.com Daily Mail and Mail on Sunday newspapers.

United-states , Department-of-justice , Administration-strike-force-on-unfair , Drug-administration , Department-of-commerce , Biosimilars-council , Biden-administration , Association-of-accessible-medicines , Bayh-dole-act , Republican-administrations , Federal-trade-commission

Fit For All Patients: Advances in IBD Therapy Expand Treatment Landscape

The past year has seen a multitude of FDA approvals, ranging from IL-23 and JAK inhibitors to biologics and subcutaneous treatment administrations, that have helped redefine what it means to treat IBD.

Chicago , Illinois , United-states , America , Elizabeth-spencer , Kimberly-kearns , Benjamin-cohen , Mirikizumab-omvoh , Biosimilar-adalimumab-adaz , Etrasimod-velsipity , Riha-bhatt , Biosimilar-adalimumab-aaty

House Committee Hearing Addresses PBMs, Anticompetitive Drug Pricing Tactics

The House Committee members examined pricing tactics by PBMs and how they are harming patients across the country.

United-states , America , James-comer , Craig-burton , Lori-reilly , Biosimilars-council , Employee-health , Medicaid-services , House-committee-on-oversight , Oversight-committee , Office-of-personnel-management , Centers-for-medicare

PBMs, PhRMA trade blame over drug costs in House hearing

Healthcare

United-states , America , Hugh-chancy , Jake-laturner , Rena-conti , Robert-garcia , Stephen-lynch , Cori-bush , Craig-burton , Lori-reilly , Jamie-raskin , James-comer

PBMs, PhRMA trade blame over drug costs in House hearing

BioPharma

United-states , America , James-comer , Rena-conti , Jake-laturner , Cori-bush , Stephen-lynch , Robert-garcia , Jamie-raskin , Hugh-chancy , Lori-reilly , Craig-burton

Regeneron deal may not reach such great heights

Regeneron is attempting to develop a monoclonal antibody that could be effective against future Covid-19 variants — suggesting that the agreement may be consequential if Regeneron succeeds.

Washington , United-states , Ohio , Florida , America , Ben-leonard , David-lim , Meganr-wilson , Joe-biden , Katherine-ellen-foley , Tammy-allen , Chelsea-cirruzzo

Common Patient Questions About Insulin Biosimilars Pertain to Classification

Nuances can lead to frequent areas of confusion.

United-states , American , Eli-lilly , Newsomec-basaglar , Goldmanj-biosimilar , National-cancer-institute , Biosimilars-council , Public-health-service , American-pharmacists-association , Mylan-pharmaceuticals , Novo-nordisk , Us-congress

Senate Bill Proposes Slashing 'Red Tape' Around Biosimilar Interchangeability

Legislation introduced by Utah Senator Mike Lee would eliminate testing to show a biosimilar can be substituted for a reference biologic product. Lee contends the current testing requirement adds costs and delays market access for these lower-cost biological medicines.

Indiana , United-states , New-mexico , Ohio , Samsung-bioepis , Samsung-bioepis-humira , Mike-lee , America-ph , Anna-nayun-kim , Mike-braun , Ben-ray-lujan , Public-health-service